News
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
- Newsrooms
- 6
- Last 3 hours
- 0 reports
- Momentum
- Quiet
0 in the 3 before
Cooling
Reports per hour, last 24 hours
How the coverage splits
Against the past week
More newsrooms than 91% of the past week’s 3579 stories, and number 15 of 271 in Tech.Part of a bigger story
Ozempic: 4 developments since Mon 9 Nov.Related
GLP-1 Jabs Linked to Scary Side Effect That’s Worse Than ‘Ozempic Face’ (shares GLP-1 and Ozempic)
1The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss.
In Fox Business’s words.2
The bigger story: Ozempic
4 developments since Mon 9 Nov. 2 more since this one.
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
You’re here6 newsrooms. Linked by Wegovy, Ozempic, drug, pose, risk, weight
- WA study reveals lifting weights is crucial to preserving muscle when taking weight-loss drugs like Ozempic
1 newsroom. Linked by Ozempic, study, weight, drug
- Weight loss drugs, such as Ozempic, to carry FDA warning about rare vision-loss side effects
1 newsroom. Linked by Ozempic, FDA, weight, drug, carry, rare
The story so far
6 newsroomsCooling- Reports
- 6
- Newsrooms and sources
- 6
- Last 3 hours
- 0
Cooling: well below its busiest stretch (0 in the last three hours, 0 in the three before).
First with it: Gizmodo, 2 hr 37 min before anyone else.
Reported by 6 newsrooms.
The numbers behind it
How it spread, where it’s heading and where the coverage is from
Reports a day, last 7 days
| Day | Stories |
|---|---|
| Thu | 0 |
| Fri | 0 |
| Sat | 0 |
| Sun | 0 |
| Mon | 0 |
| Tue | 4 |
| Today | 2 |
Where the coverage is from
How it spread
Newsrooms reporting it, each counted at its first report.
Sky News
CNBC
Hindustan Times
Gizmodo
Ars Technica
Gizmodo
Sky News
Hindustan Times
CNBC
Fox Business
Ars Technica